New lab test aims to predict immunotherapy success in bladder cancer

NCT ID NCT06738797

Recruiting now Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jan 30, 2026 · Last updated May 21, 2026 · Updated 20 times

Summary

This study is testing a new lab test called SPHERTEST to see if it can predict whether immunotherapy will work for people with advanced bladder cancer. Researchers will take blood and tumor samples from 32 patients to build a 3D cell model. The goal is to find a way to personalize treatment and avoid giving ineffective drugs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU de Nimes
RECRUITING

Nîmes, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Centre Antoine Lacassagne
NOT_YET_RECRUITING

Nice, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Institut Régional du Cancer de Montpellier
NOT_YET_RECRUITING

Montpellier, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Institut du Cancer de Montpellier
NOT_YET_RECRUITING

Montpellier, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Iuct Oncopole
RECRUITING

Toulouse, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

UROGENITAL NEOPLASMS